In 2024, we revolutionize cancer treatment by using the tumor-associated microbiome as a metaphoric trojan horse! Our project targets tumor-specific bacteria to deliver precision treatment and combat tumor growth.
We're developing a new colorectal cancer treatment that targets bacteria predominantly found within tumors. Our approach delivers potent toxins directly to the tumor site, selectively destroying cancer cells.
Traditional cancer therapies can be harsh and don't always fully eliminate tumors. Our bacteria-targeting approach aims to provide a more precise, less toxic treatment with improved outcomes for colorectal cancer patients.
We identify bacteria predominant to colorectal tumors and design a fusion protein that binds specifically to them. The enzyme of our fusion protein converts a non-toxic prodrug to a potent cytotoxin. This creates a targeted weapon that selectively destroys cancer cells within the tumor environment.
Your support empowers our iGEM team to develop our skills and pursue groundbreaking research in cancer treatment. Furthermore, the students acquire soft skills, whereby your support contributes to the development of a new generation of leaders. Help us grow as scientists and people and contribute to advancements in the field.
